Francisco Kuribreña of Landsteiner Scientific's 2015 Presentation is now available for download.
At last year's World Biosimilar Congress USA, we were excited to have Francisco Kuribreña, Director of New Development at Landsteiner Scientific, share his expertise on institutional experiences in preclinical evaluation of biosimilars in Mexico.
You can now download his presentation to find out more about:
-
The emerging Mexican economy
-
Mexico and the pharma business
-
The drug agency in Mexico
-
Understanding the pharamceutical registration in Mexico
-
Registration of non-original biologics before 2011